arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

SANUWAVE Health, Inc.

SNWV
$4.71 ▲ +0.14 (+3.06%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
44
Health
Weak
Moderately Bullish
auto_awesome

Analytical Summary

SANUWAVE Health, Inc. demonstrates solid fundamentals with strength in Profit Margin (%). However, watch Return on Common Equity (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $40.3M
Dividend Yield —
Revenue Growth 35.0% ↘
Op. Margin 11.2% ↘
ROIC 34.3% ↗
FCF / Share $0.23 ↘
Trailing P/E 3.4x
Price / Book —
FCF Yield 4.8%
Debt / Equity -2.88
info Valuation on last close. End-of-day price, Sep 23, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$44.05M
↑ +35.0% —
Net Income Profit after all expenses
$11.81M
↑ +135.7% —
Operating Margin Operating profit as % of sales
11.2%
↓ -4.8% 59th
FCF / Share Free cash flow per share
$0.23
↓ -48.7% —
Long-Term Debt Long-term obligations
$21.89M
↓ -16.6% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
63
Returns
4
Financial Health ↓
78
Cash Quality ↓
28

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters